Managers / Q1 2019 · view latest →
SYQUANT CAPITAL SAS
CIK 0001766392 · 25 AVENUE KLEBER, PARIS, I0, 75116 · 0033142569307
Summary
Syquant Capital Sas reported $258M in U.S.-listed holdings across 15 positions for Q1 2019.
The portfolio is heavily concentrated: Spark Therapeutics alone accounts for 24.6% of reported value.
Compared with Q4 2018, the fund opened 11 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 44.2% · $114M
- Other · 42.8% · $111M
- Closed-End Fund · 10.6% · $27M
- ADR · 2.5% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2018 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPARK THERAPEUTICS INC | NEW | +558.5K | 558.5K | +$64M | $64M |
| ULTIMATE SOFTWARE GROUP INC | NEW | +108.3K | 108.3K | +$36M | $36M |
| ELLIE MAE INC | NEW | +165.4K | 165.4K | +$16M | $16M |
| ARRIS INTERNATIONAL PLC | NEW | +505.8K | 505.8K | +$16M | $16M |
| DISDISNEY WALT CO | NEW | +65.3K | 65.3K | +$7M | $7M |
| GNFTYGENFIT S A | NEW | +266.8K | 266.8K | +$6M | $6M |
| WABWABTEC CORP | NEW | +82.8K | 82.8K | +$6M | $6M |
| PACBPACIFIC BIOSCIENCES CALIF IN | NEW | +496.1K | 496.1K | +$4M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SPARK THERAPEUTICS INC | COM | 24.61% | $64M | 558.5K |
| 2 | INTEGRATED DEVICE TECHNOLOGY | COM | 14.26% | $37M | 752.3K |
| 3 | ULTIMATE SOFTWARE GROUP INC | COM | 13.83% | $36M | 108.3K |
| 4 | ALTABA INC | COM | 10.56% | $27M | 368.3K |
| 5 | RED HAT INC | COM | 8.29% | $21M | 117.3K |
| 6 | ELLIE MAE INC | COM | 6.32% | $16M | 165.4K |
| 7 | ARRIS INTERNATIONAL PLC | SHS | 6.19% | $16M | 505.8K |
| 8 | AVAAVISTA CORPhistory → | COM | 3.89% | $10M | 247.6K |
| 9 | DISDISNEY WALT COhistory → | COM | 2.80% | $7M | 65.3K |
| 10 | GNFTYGENFIT S Ahistory → | ADS | 2.48% | $6M | 266.8K |
| 11 | WABWABTEC CORPhistory → | COM | 2.36% | $6M | 82.8K |
| 12 | PACBPACIFIC BIOSCIENCES CALIF INhistory → | COM | 1.39% | $4M | 496.1K |
| 13 | TRAVELPORT WORLDWIDE LTD | SHS | 1.22% | $3M | 200.0K |
| 14 | U S G CORP | COM | 0.95% | $2M | 56.7K |
| 15 | RIGTRANSOCEAN LTD | SHS | 0.84% | $2M | 250.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $447M | 38 | Jul 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $640M | 40 | Apr 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $817M | 37 | Jan 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $348M | 17 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $302M | 14 | Jul 18, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $141M | 14 | Apr 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $70M | 6 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $27M | 5 | Oct 4, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $10M | 5 | Jul 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $64M | 6 | Apr 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $22M | 7 | Jan 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $255M | 9 | Oct 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $138M | 11 | Jul 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $43M | 7 | Apr 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $41M | 14 | Jan 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $165M | 25 | Oct 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $90M | 32 | Jul 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $195M | 35 | Apr 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $262M | 43 | Jan 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $164M | 42 | Oct 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $83M | 41 | Jul 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $386M | 53 | Apr 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $387M | 81 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $196M | 62 | Oct 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $215M | 23 | Aug 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $407M | 18 | Apr 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $194M | 16 | Jan 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $365M | 17 | Oct 17, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $312M | 14 | Jul 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $258M | 15 | Apr 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $117M | 11 | Feb 4, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.